Search Results - "Drabkin, H A"

Refine Results
  1. 1

    HOX expression patterns identify a common signature for favorable AML by Andreeff, M, Ruvolo, V, Gadgil, S, Zeng, C, Coombes, K, Chen, W, Kornblau, S, Barón, A E, Drabkin, H A

    Published in Leukemia (01-11-2008)
    “…Deregulated HOX expression, by chromosomal translocations and myeloid-lymphoid leukemia (MLL) rearrangements, is causal in some types of leukemia. Using…”
    Get full text
    Journal Article
  2. 2

    High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer by BREMNES, R. M, VEVE, R, GABRIELSON, E, HIRSCH, F. R, BARON, A, BEMIS, L, GEMMILL, R. M, DRABKIN, H. A, FRANKLIN, W. A

    Published in Journal of clinical oncology (15-05-2002)
    “…E-cadherin (E-cad) and its associated intracellular molecules, catenins, are critical for intercellular epithelial adhesion and are often expressed in…”
    Get full text
    Journal Article
  3. 3

    Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia by DRABKIN, H. A, PARSY, C, GEMMILL, R, BRIZARD, F, BRIZARD, A, ROCHE, J, FERGUSON, K, GUILHOT, F, LACOTTE, L, ROY, L, ZENG, C, BARON, A, HUNGER, S. P, VARELLA-GARCIA, M

    Published in Leukemia (01-02-2002)
    “…We used a degenerate RT-PCR screen and subsequent real-time quantitative RT-PCR assays to examine the expression of HOX and TALE-family genes in 34 cases of…”
    Get full text
    Journal Article
  4. 4

    A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer by Dasari, A., Gore, L., Messersmith, W. A., Diab, S., Jimeno, A., Weekes, C. D., Lewis, K. D., Drabkin, H. A., Flaig, T. W., Camidge, D. R.

    Published in Investigational new drugs (01-02-2013)
    “…Summary Background This phase I study evaluated the safety, tolerability and preliminary efficacy of sorafenib combined with vorinostat in patients with solid…”
    Get full text
    Journal Article
  5. 5

    Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas by UEDA, M, GEMMILL, R. M, WEST, J, WINN, R, SUGITA, M, TANAKA, N, UEKI, M, DRABKIN, H. A

    Published in British journal of cancer (06-07-2001)
    “…Beta-catenin forms complexes with Tcf and Lef-1 and functions as a transcriptional activator in the Wnt signalling pathway. Although recent investigations have…”
    Get full text
    Journal Article
  6. 6

    Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma by GEMMILL, R. M, ZHOU, M, COSTA, L, KORCH, C, BUKOWSKI, R. M, DRABKIN, H. A

    Published in British journal of cancer (20-06-2005)
    “…Epidermal growth factor receptor (EGFR) and tumour growth factor alpha (TGFalpha) are frequently overexpressed in renal cell carcinoma (RCC) yet responses to…”
    Get full text
    Journal Article
  7. 7

    RING-dependent tumor suppression and G2 M arrest induced by the TRC8 hereditary kidney cancer gene by BRAUWEILER, A, LORICK, K. L, LEE, J. P, TSAI, Y. C, CHAN, D, WEISSMAN, A. M, DRABKIN, H. A, GEMMILL, R. M

    Published in Oncogene (05-04-2007)
    “…TRC8/RNF139 and von Hippel-Lindau (VHL) both encode E3 ubiquitin (Ub) ligases mutated in clear-cell renal carcinomas (ccRCC). VHL, inactivated in nearly 70% of…”
    Get full text
    Journal Article
  8. 8

    Chromosome 3p14 Homozygous Deletions and Sequence Analysis of FRA3B by Boldog, Ferenc, Gemmill, Robert M., West, James, Robinson, Misi, Robinson, Linda, Li, Efang, Roche, Joelle, Todd, Sean, Waggoner, Barbara, Lundstrom, Ron, Jacobson, Jan, Mullokandov, Michael R., Klinger, Harold, Drabkin, Harry A.

    Published in Human molecular genetics (01-02-1997)
    “…Loss of heterozygosity (LOH) involving 3p occurs in many carcinomas but is complicated by the identification of four distinct homozygous deletion regions. One…”
    Get full text
    Journal Article
  9. 9

    Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics by ROCHE, J, ZENG, C, BARON, A, GADGIL, S, GEMMILL, R. M, TIGAUD, I, THOMAS, X, DRABKIN, H. A

    Published in Leukemia (01-06-2004)
    “…We previously reported that favorable and poor prognostic chromosomal rearrangements in acute myeloid leukemia (AML) were associated with distinct levels of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation by DOWNING, J. R, HEAD, D. R, CIVIN, C. I, ERICKSON, P, CURCIO-BRINT, A. M, HULSHOF, M. G, MOTRONI, T. A, RAIMONDI, S. C, CARROLL, A. J, DRABKIN, H. A, WILLMAN, C, THEIL, K. S

    Published in Blood (01-06-1993)
    “…The 8;21 translocation is one of the most common chromosomal translocations in acute myelogenous leukemia (AML), accounting for 40% of pediatric AML with…”
    Get full text
    Journal Article
  12. 12

    Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting by VARELLA-GARCIA, M, HOGAN, C. J, MCGAVRAN, L, GEMMILL, R. M, BERGER, R, DRABKIN, H. A, ODOM, L. F, MURATA-COLLINS, I. L, AI, H, CHEN, L, RICHKIND, K, PASKULIN, G, ANDREEFF, M, BRIZARD, A

    Published in Leukemia (01-09-2001)
    “…Many patients with t(8;21) AML have residual positive cells during remission. We previously developed D-FISH probes that detect both derivative chromosomes and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors : Implications for t(8;21) leukemogenesis and monitoring residual disease by ERICKSON, P. F, DESSEV, G, LASHER, R. S, PHILIPS, G, ROBINSON, M, DRABKIN, H. A

    Published in Blood (01-09-1996)
    “…To study acute myelogenous leukemia 1 (AML1) transcription factor, ETO protein, and t(8;21) AML chimeric AML1/ ETO protein in normal hematopoiesis and in…”
    Get full text
    Journal Article
  15. 15

    Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel alpha-subunit gene (SCN5A) to band 3p21 by George, Jr, A L, Varkony, T A, Drabkin, H A, Han, J, Knops, J F, Finley, W H, Brown, G B, Ward, D C, Haas, M

    Published in Cytogenetics and cell genetics (01-01-1995)
    “…The chromosomal location of SCN5A, the gene encoding the principal voltage-gated Na+ channel expressed in human heart, has been determined by three independent…”
    Get more information
    Journal Article
  16. 16

    Detection of DNA Rearrangements in the AML1 and ETO Loci and of an AML1/ETO Fusion mRNA in Patients With t(8;21) Acute Myeloid Leukemia by Nucifora, Giuseppina, Birn, Debra J., Erickson, Paul, Gao, Jizong, LeBeau, Michelle M., Drabkin, Harry A., Rowley, Janet D.

    Published in Blood (15-02-1993)
    “…The (8;21)(q22;q22) translocation is a frequent karyotypic abnormality seen in approximately 40% of patients with acute myeloid leukemia subtype M2 (AML-M2)…”
    Get full text
    Journal Article
  17. 17

    Homozygous deletions of human chromosome 3p in lung tumors by TODD, S, FRANKLIN, W. A, VARELLA-GARCIA, M, KENNEDY, T, HILLIKER, C. E, HAHNER, L. JR, ANDERSON, M, WIEST, J. S, DRABKIN, H. A, GEMMILL, R. M

    Published in Cancer research (Chicago, Ill.) (01-04-1997)
    “…Cytogenetic and loss of heterozygosity (LOH) studies have demonstrated that deletions of chromosome 3p occur at a high frequency in all forms of lung cancer…”
    Get full text
    Journal Article
  18. 18

    The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor by ERICKSON, P. F, ROBINSON, M, OWENS, G, DRABKIN, H. A

    Published in Cancer research (Chicago, Ill.) (01-04-1994)
    “…The 8;21 translocation, t(8;21)(q22;q22.3), is seen only in acute myelogenous leukemia and is characteristically associated with the M2 subtype. Subsequent to…”
    Get full text
    Journal Article
  19. 19

    Positional Cloning of the Hereditary Renal Carcinoma 3;8 Chromosome Translocation Breakpoint by Boldog, Ferenc L., Gemmill, Robert M., Wilke, Charles M., Glover, Thomas W., Nilsson, Ann-Sofie, Chandrasekharappa, Settara C., Brown, Robert S., Li, Frederick P., Drabkin, Harry A.

    “…The chromosome (p14.2;q24.1) translocation t(3;8)has been associated with hereditary renal cancer in one family. Based on cytogenetic analyses and…”
    Get full text
    Journal Article
  20. 20

    DEF-3(G16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC by DRABKIN, H. A, WEST, J. D, HOTFILDER, M, HENG, Y. M, ERICKSON, P, CALVO, R, DALMAU, J, GEMMILL, R. M, SABLITZKY, F

    Published in Oncogene (22-04-1999)
    “…DEF-3(g16/NY-LU-12) encodes a novel RNA binding protein isolated by positional cloning from an SCLC homozygous deletion region in 3p21.3 and, in parallel, as a…”
    Get full text
    Journal Article